Elizabeth K. Schiffman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elizabeth K. Schiffman has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Jenna K. H. Bjork
Minnesota Department of Health, 625 Robert Street North, Saint Paul, MN 55155, USA
4 shared publications - Rebecca J. Eisen
Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, USA
3 shared publications - Alison F. Hinckley
Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA
2 shared publications - Beth Kristine Thielen
Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Minnesota Medical School , Minneapolis, MN
2 shared publications - Brad J. Biggerstaff
Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA
2 shared publications - Christopher Faulk
University of Minnesota
2 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by Elsevier in One Health
- Vol. 23, 101507
Climate and other environmental factors predict tick abundance and Lyme cases in Minnesota one and two years in advance
- 3 July 2026
- Published by Elsevier in One Health
- Vol. 23, 101507
Open AccessClimate and other environmental factors predict tick abundance and Lyme cases in Minnesota one and two years in advance
- Open Access
- 6 August 2025
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 16 (5) , 102531
Willingness to pay for residential property-based and community-based tick control methods in Lyme disease-endemic areas of the Upper Midwest, United States
- 6 August 2025
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 16 (5) , 102531
Open AccessWillingness to pay for residential property-based and community-based tick control methods in Lyme disease-endemic areas of the Upper Midwest, United States
- 17 July 2025
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 31 (5) , 877-885
Active and Passive Vector Surveillance Systems in Lyme Endemic Minnesota and Their Correlation to Human Disease
Context: Vector surveillance is often used to predict tick-borne diseases in endemic regions. Active and passive vector surveillance systems offer differing benefits and limitations; understanding how the outputs of these systems differ and how they correlate to human disease is essential to public health decision-making. Active and passive vector surveillance systems in Minnesota between 2018 and 2023 present an opportunity for comparison between these surveillance methods. Objective: To (1) analyze, compare, and contrast the results of active vector surveillance with crowd-sourced approaches, and (2) explore how these sources predict risk of Lyme disease. Methods: In this ecological comparative analysis, descriptive statistics were performed to evaluate characteristics of each surveillance method to assess differences in seasonality, life stage, and species of ticks. Negative binomial regression was used to analyze correlation to Lyme disease. Results: There are differences between data sources in tick life stage, species, and seasonality. Active surveillance using small mammal trapping had a majority larval (85%) and I. scapularis (76%) ticks. In contrast, passive surveillance had a majority of adult (96%) and D. variabilis (75%) ticks. Observations in both data sources were skewed to the early third of the tick season, although this was more exaggerated in the passive surveillance data. Observations of ticks from both data sources positively correlated with cases of Lyme disease. Conclusions: Observed differences in tick characteristics between the 2 data sources may represent real differences between tick populations and human encounters. Some differences may be explained by observation, reporting, and sampling biases. Increased observations of ticks at the beginning of the season indicate potential utility of enhanced human Lyme disease surveillance at that time. These One Health findings signal an opportunity for early identification of high tick-borne disease years through integrated active and passive tick surveillance that informs the conduct of human disease surveillance.
- 17 July 2025
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 31 (5) , 877-885
Active and Passive Vector Surveillance Systems in Lyme Endemic Minnesota and Their Correlation to Human Disease
Context: Vector surveillance is often used to predict tick-borne diseases in endemic regions. Active and passive vector surveillance systems offer differing benefits and limitations; understanding how the outputs of these systems differ and how they correlate to human disease is essential to public health decision-making. Active and passive vector surveillance systems in Minnesota between 2018 and 2023 present an opportunity for comparison between these surveillance methods. Objective: To (1) analyze, compare, and contrast the results of active vector surveillance with crowd-sourced approaches, and (2) explore how these sources predict risk of Lyme disease. Methods: In this ecological comparative analysis, descriptive statistics were performed to evaluate characteristics of each surveillance method to assess differences in seasonality, life stage, and species of ticks. Negative binomial regression was used to analyze correlation to Lyme disease. Results: There are differences between data sources in tick life stage, species, and seasonality. Active surveillance using small mammal trapping had a majority larval (85%) and I. scapularis (76%) ticks. In contrast, passive surveillance had a majority of adult (96%) and D. variabilis (75%) ticks. Observations in both data sources were skewed to the early third of the tick season, although this was more exaggerated in the passive surveillance data. Observations of ticks from both data sources positively correlated with cases of Lyme disease. Conclusions: Observed differences in tick characteristics between the 2 data sources may represent real differences between tick populations and human encounters. Some differences may be explained by observation, reporting, and sampling biases. Increased observations of ticks at the beginning of the season indicate potential utility of enhanced human Lyme disease surveillance at that time. These One Health findings signal an opportunity for early identification of high tick-borne disease years through integrated active and passive tick surveillance that informs the conduct of human disease surveillance.
- Open Access
- 9 June 2025
- Published by Oxford University Press (OUP) in G3: Genes, Genomes, Genetics
- Vol. 15 (8)
The genome of the American dog tick (Dermacentor variabilis)
The American dog tick (Dermacentor variabilis) is a vector of zoonotic pathogens in North America that poses emerging threats to public health. Despite its medical importance, genomic resources for D. variabilis remain scarce. Leveraging long-read nanopore sequencing, we generated a high-quality genome assembly for D. variabilis with a final size of 2.15 Gb, an N50 of 445 kb, and a benchmarking universal single-copy ortholog (BUSCO) completeness score of 95.2%. Comparative BUSCO analyses revealed fewer duplicate genes in our assembly than in other Dermacentor genomes, indicating improved haplotype resolution. The mitochondrial genome, assembled as a single circular contig, clustered monophyletically with D. variabilis isolates from the Upper Midwest, corroborating regional phylogenetic relationships. Repetitive element analysis identified 61% of the genome as repetitive, dominated by long interspersed nuclear elements and long terminal repeat elements, with 24% remaining unclassified, underscoring the need for further exploration of transposable elements in tick genomes. Gene annotation predicted 21,722 putative genes, achieving a protein BUSCO completeness of 80.88%. Additionally, genome-wide methylation analysis revealed 9.9% global 5mC methylation, providing the first insights into epigenetic modifications in D. variabilis. Further, nanopore sequencing detected Rickettsia montanensis and a nonpathogenic Francisella-like endosymbiont. These findings expand our understanding of tick genomics and epigenetics, offering valuable resources for comparative studies and evolutionary analyses.
- 9 June 2025
- Published by Oxford University Press (OUP) in G3: Genes, Genomes, Genetics
- Vol. 15 (8)
Open AccessThe genome of the American dog tick (Dermacentor variabilis)
The American dog tick (Dermacentor variabilis) is a vector of zoonotic pathogens in North America that poses emerging threats to public health. Despite its medical importance, genomic resources for D. variabilis remain scarce. Leveraging long-read nanopore sequencing, we generated a high-quality genome assembly for D. variabilis with a final size of 2.15 Gb, an N50 of 445 kb, and a benchmarking universal single-copy ortholog (BUSCO) completeness score of 95.2%. Comparative BUSCO analyses revealed fewer duplicate genes in our assembly than in other Dermacentor genomes, indicating improved haplotype resolution. The mitochondrial genome, assembled as a single circular contig, clustered monophyletically with D. variabilis isolates from the Upper Midwest, corroborating regional phylogenetic relationships. Repetitive element analysis identified 61% of the genome as repetitive, dominated by long interspersed nuclear elements and long terminal repeat elements, with 24% remaining unclassified, underscoring the need for further exploration of transposable elements in tick genomes. Gene annotation predicted 21,722 putative genes, achieving a protein BUSCO completeness of 80.88%. Additionally, genome-wide methylation analysis revealed 9.9% global 5mC methylation, providing the first insights into epigenetic modifications in D. variabilis. Further, nanopore sequencing detected Rickettsia montanensis and a nonpathogenic Francisella-like endosymbiont. These findings expand our understanding of tick genomics and epigenetics, offering valuable resources for comparative studies and evolutionary analyses.
- 26 March 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (2) , 397-402
Jamestown Canyon Virus Seroprevalence in Endemic Regions and Implications for Diagnostic Testing
Background: Jamestown Canyon virus, a mosquito-borne virus, can cause asymptomatic infection, febrile illness, or neuroinvasive disease in humans. Previous studies have found Jamestown Canyon virus–specific antibodies in a 4%–54% of people in various U.S. regions. To understand baseline seroprevalence in regions with the highest number of reported disease cases, we performed a serosurvey among blood donors. Methods: We randomly selected blood donation specimens collected during December 2019–April 2020 from residents of counties reporting ≥2 disease cases in 2019 or 1 case in 2019 and ≥1 case during 2010–2018. Specimens were screened for Jamestown Canyon virus–specific neutralizing antibodies and, if positive, tested for immunoglobulin M (IgM) antibodies. We estimated county population seroprevalence by calibrating sample weights to population census data. Results: Fourteen counties in 3 states, Massachusetts, Minnesota, and Wisconsin, met the inclusion criteria. Within each state, average county seroprevalence ranged from 16.8% (95% confidence interval [CI], 9.3–27.0) to 18.8% (95% CI, 14.0–24.4) for Jamestown Canyon virus–neutralizing antibodies and from 7.6% (95% CI, 4.2–12.5) to 13.5% (95% CI, 9.6–18.3) for both neutralizing and IgM antibodies. Conclusions: Estimated Jamestown Canyon virus seroprevalence, including for IgM antibodies, is elevated in endemic areas, complicating the interpretation of serologic testing in diagnosing acute disease in symptomatic individuals. Diagnosing Jamestown Canyon virus disease requires a high degree of clinical suspicion, ruling out other possible causes of illness, and if possible, collecting acute and convalescent samples. New assays to detect acute infection could improve diagnosis and public health surveillance for Jamestown Canyon virus disease.
- 26 March 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (2) , 397-402
Jamestown Canyon Virus Seroprevalence in Endemic Regions and Implications for Diagnostic Testing
Background: Jamestown Canyon virus, a mosquito-borne virus, can cause asymptomatic infection, febrile illness, or neuroinvasive disease in humans. Previous studies have found Jamestown Canyon virus–specific antibodies in a 4%–54% of people in various U.S. regions. To understand baseline seroprevalence in regions with the highest number of reported disease cases, we performed a serosurvey among blood donors. Methods: We randomly selected blood donation specimens collected during December 2019–April 2020 from residents of counties reporting ≥2 disease cases in 2019 or 1 case in 2019 and ≥1 case during 2010–2018. Specimens were screened for Jamestown Canyon virus–specific neutralizing antibodies and, if positive, tested for immunoglobulin M (IgM) antibodies. We estimated county population seroprevalence by calibrating sample weights to population census data. Results: Fourteen counties in 3 states, Massachusetts, Minnesota, and Wisconsin, met the inclusion criteria. Within each state, average county seroprevalence ranged from 16.8% (95% confidence interval [CI], 9.3–27.0) to 18.8% (95% CI, 14.0–24.4) for Jamestown Canyon virus–neutralizing antibodies and from 7.6% (95% CI, 4.2–12.5) to 13.5% (95% CI, 9.6–18.3) for both neutralizing and IgM antibodies. Conclusions: Estimated Jamestown Canyon virus seroprevalence, including for IgM antibodies, is elevated in endemic areas, complicating the interpretation of serologic testing in diagnosing acute disease in symptomatic individuals. Diagnosing Jamestown Canyon virus disease requires a high degree of clinical suspicion, ruling out other possible causes of illness, and if possible, collecting acute and convalescent samples. New assays to detect acute infection could improve diagnosis and public health surveillance for Jamestown Canyon virus disease.
- Open Access
The Genome of the American Dog Tick ( Dermacentor variabilis )
The American dog tick ( Dermacentor variabilis ) is a vector of zoonotic pathogens in North America that poses emerging threats to public health. Despite its medical importance, genomic resources for D. variabilis remain scarce. Leveraging long-read nanopore sequencing, we generated a high-quality genome assembly for D. variabilis with a final size of 2.15 Gb, an N50 of 445 kb, and a BUSCO completeness score of 95.2%. Comparative BUSCO analyses revealed fewer duplicate genes in our assembly than in other Dermacentor genomes, indicating improved haplotype resolution. The mitochondrial genome, assembled as a single circular contig, clustered monophyletically with D. variabilis isolates from the Upper Midwest, corroborating regional phylogenetic relationships. Repetitive element analysis identified 61% of the genome as repetitive, dominated by LINEs and LTR elements, with 24% remaining unclassified, underscoring the need for further exploration of transposable elements in tick genomes. Gene annotation predicted 21,722 putative genes, achieving a protein BUSCO completeness of 80.88%. Additionally, genome-wide methylation analysis revealed 9.9% global 5mC methylation, providing the first insights into epigenetic modifications in D. variabilis . Further, nanopore sequencing detected Rickettsia montanensis and a non-pathogenic Francisella -like endosymbiont. These findings expand our understanding of tick genomics and epigenetics, offering valuable resources for comparative studies and evolutionary analyses.
Open AccessThe Genome of the American Dog Tick ( Dermacentor variabilis )
The American dog tick ( Dermacentor variabilis ) is a vector of zoonotic pathogens in North America that poses emerging threats to public health. Despite its medical importance, genomic resources for D. variabilis remain scarce. Leveraging long-read nanopore sequencing, we generated a high-quality genome assembly for D. variabilis with a final size of 2.15 Gb, an N50 of 445 kb, and a BUSCO completeness score of 95.2%. Comparative BUSCO analyses revealed fewer duplicate genes in our assembly than in other Dermacentor genomes, indicating improved haplotype resolution. The mitochondrial genome, assembled as a single circular contig, clustered monophyletically with D. variabilis isolates from the Upper Midwest, corroborating regional phylogenetic relationships. Repetitive element analysis identified 61% of the genome as repetitive, dominated by LINEs and LTR elements, with 24% remaining unclassified, underscoring the need for further exploration of transposable elements in tick genomes. Gene annotation predicted 21,722 putative genes, achieving a protein BUSCO completeness of 80.88%. Additionally, genome-wide methylation analysis revealed 9.9% global 5mC methylation, providing the first insights into epigenetic modifications in D. variabilis . Further, nanopore sequencing detected Rickettsia montanensis and a non-pathogenic Francisella -like endosymbiont. These findings expand our understanding of tick genomics and epigenetics, offering valuable resources for comparative studies and evolutionary analyses.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2025 (1) , 4453384
Powassan Virus Encephalitis in an Immunocompromised Patient: A Diagnostic Challenge With Case Report and Literature Review
Powassan virus (POWV) is a tick‐borne flavivirus transmitted to humans by Ixodes ticks. In this report, we describe an immunocompromised patient who presented with progressive neurologic symptoms and was diagnosed with POWV encephalitis. Additionally, the patient tested positive for Jamestown Canyon virus (JCV), a mosquito‐borne orthobunyavirus , creating a diagnostic dilemma. This case underscores the importance of considering vector‐borne illnesses in immunocompromised individuals who present with neurologic symptoms, particularly during peak arboviral transmission seasons in the United States. It also highlights the complexities of laboratory testing for arboviral infections in these vulnerable patients.
- 1 January 2025
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2025 (1) , 4453384
Open AccessPowassan Virus Encephalitis in an Immunocompromised Patient: A Diagnostic Challenge With Case Report and Literature Review
Powassan virus (POWV) is a tick‐borne flavivirus transmitted to humans by Ixodes ticks. In this report, we describe an immunocompromised patient who presented with progressive neurologic symptoms and was diagnosed with POWV encephalitis. Additionally, the patient tested positive for Jamestown Canyon virus (JCV), a mosquito‐borne orthobunyavirus , creating a diagnostic dilemma. This case underscores the importance of considering vector‐borne illnesses in immunocompromised individuals who present with neurologic symptoms, particularly during peak arboviral transmission seasons in the United States. It also highlights the complexities of laboratory testing for arboviral infections in these vulnerable patients.
- Open Access
- 12 March 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (3) , e0229565
Barriers to malaria prevention among immigrant travelers in the United States who visit friends and relatives in sub-Saharan Africa: A cross-sectional, multi-setting survey of knowledge, attitudes, and practices
Despite achievements in the reduction of malaria globally, imported malaria cases to the United States by returning international travelers continue to increase. Immigrants to the United States from sub-Saharan Africa (SSA) who then travel back to their homelands to visit friends and relatives (VFRs) experience a disproportionate burden of malaria illness. Various studies have explored barriers to malaria prevention among VFRs and non-VFRs–travelers to the same destinations with other purpose for travel–but few employed robust epidemiologic study designs or performed comparative analyses of these two groups. To better quantify the key barriers that VFRs face to implement effective malaria prevention measures, we conducted a comprehensive community-based, cross-sectional, survey to identify differences in malaria prevention knowledge, attitudes, and practices (KAP) among VFRs and others traveling to Africa and describe the differences between VFRs and other types of international travelers. Three distinct populations of travelers with past or planned travel to malaria-endemic countries of SSA were surveyed: VFRs diagnosed with malaria as reported through a state health department; members of the general VFR population (community); and VFR and non-VFR travelers presenting to a travel health clinic, both before their pretravel consultation and again, after return from travel. A Community Advisory Board of African immigrants and prior qualitative research informed survey development and dissemination. Across the three groups, 489 travelers completed surveys: 351 VFRs and 138 non-VFRs. VFRs who reported taking antimalarials on their last trip rated their concern about malaria higher than those who did not. Having taken five or more trips to SSA was reported more commonly among VFRs diagnosed with malaria than community VFRs (44.0% versus 20.4%; p = 0.008). Among travel health clinic patients surveyed before and after travel, VFR travelers were less successful than non-VFRs in adhering to their planned use of antimalarials (82.2% versus 98.7%; p = 0.001) and employing mosquito bite avoidance techniques (e.g., using bed nets: 56.8% versus 81.8%; p = 0.009). VFRs who visited the travel health clinic were more likely than VFR respondents from the community to report taking an antimalarial (83.0% versus 61.9%; p = 0.009), or to report bite avoidance behaviors (e.g., staying indoors when mosquitoes were out: 80.9% versus 59.5%; p = 0.009). We observed heterogeneity in malaria prevention behaviors among VFRs and between VFR and non-VFR traveler populations. Although VFRs attending the travel health clinic appear to demonstrate better adherence to malaria prevention measures than VFR counterparts surveyed in the community, specialized pretravel care is not sufficient to ensure chemoprophylaxis use and bite avoidance behaviors among VFRs. Even when seeking specialized pretravel care, VFRs experience greater barriers to the use of malaria prevention than non-VFRs. Addressing access to health care and upstream barrier reduction strategies that make intended prevention more achievable, affordable, easier, and resonant among VFRs may improve malaria prevention intervention effectiveness.
- 12 March 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (3) , e0229565
Open AccessBarriers to malaria prevention among immigrant travelers in the United States who visit friends and relatives in sub-Saharan Africa: A cross-sectional, multi-setting survey of knowledge, attitudes, and practices
Despite achievements in the reduction of malaria globally, imported malaria cases to the United States by returning international travelers continue to increase. Immigrants to the United States from sub-Saharan Africa (SSA) who then travel back to their homelands to visit friends and relatives (VFRs) experience a disproportionate burden of malaria illness. Various studies have explored barriers to malaria prevention among VFRs and non-VFRs–travelers to the same destinations with other purpose for travel–but few employed robust epidemiologic study designs or performed comparative analyses of these two groups. To better quantify the key barriers that VFRs face to implement effective malaria prevention measures, we conducted a comprehensive community-based, cross-sectional, survey to identify differences in malaria prevention knowledge, attitudes, and practices (KAP) among VFRs and others traveling to Africa and describe the differences between VFRs and other types of international travelers. Three distinct populations of travelers with past or planned travel to malaria-endemic countries of SSA were surveyed: VFRs diagnosed with malaria as reported through a state health department; members of the general VFR population (community); and VFR and non-VFR travelers presenting to a travel health clinic, both before their pretravel consultation and again, after return from travel. A Community Advisory Board of African immigrants and prior qualitative research informed survey development and dissemination. Across the three groups, 489 travelers completed surveys: 351 VFRs and 138 non-VFRs. VFRs who reported taking antimalarials on their last trip rated their concern about malaria higher than those who did not. Having taken five or more trips to SSA was reported more commonly among VFRs diagnosed with malaria than community VFRs (44.0% versus 20.4%; p = 0.008). Among travel health clinic patients surveyed before and after travel, VFR travelers were less successful than non-VFRs in adhering to their planned use of antimalarials (82.2% versus 98.7%; p = 0.001) and employing mosquito bite avoidance techniques (e.g., using bed nets: 56.8% versus 81.8%; p = 0.009). VFRs who visited the travel health clinic were more likely than VFR respondents from the community to report taking an antimalarial (83.0% versus 61.9%; p = 0.009), or to report bite avoidance behaviors (e.g., staying indoors when mosquitoes were out: 80.9% versus 59.5%; p = 0.009). We observed heterogeneity in malaria prevention behaviors among VFRs and between VFR and non-VFR traveler populations. Although VFRs attending the travel health clinic appear to demonstrate better adherence to malaria prevention measures than VFR counterparts surveyed in the community, specialized pretravel care is not sufficient to ensure chemoprophylaxis use and bite avoidance behaviors among VFRs. Even when seeking specialized pretravel care, VFRs experience greater barriers to the use of malaria prevention than non-VFRs. Addressing access to health care and upstream barrier reduction strategies that make intended prevention more achievable, affordable, easier, and resonant among VFRs may improve malaria prevention intervention effectiveness.
- Open Access
- 6 June 2018
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 98 (6) , 1671-1682
An Acarological Risk Model Predicting the Density and Distribution of Host-Seeking Ixodes scapularis Nymphs in Minnesota
Ixodes scapularis is the vector of at least seven human pathogens in Minnesota, two of which are known to cause Lyme disease (Borrelia burgdorferi sensu stricto and Borrelia mayonii). In Minnesota, the statewide incidence of Lyme disease and other I. scapularis–borne diseases and the geographic extent over which cases have been reported have both increased substantially over the last two decades. These changes correspond with an expanding distribution of I. scapularis over a similar time frame. Because the risk of exposure to I. scapularis–borne pathogens is likely related to the number of ticks encountered, we developed an acarological risk model predicting the density of host-seeking I. scapularis nymphs (DON) in Minnesota. The model was informed by sampling 81 sites located in 42 counties in Minnesota. Two main foci were predicted by the model to support elevated densities of host-seeking I. scapularis nymphs, which included the seven-county Minneapolis-St. Paul metropolitan area and counties in northern Minnesota, including Lake of the Woods and Koochiching counties. There was substantial heterogeneity observed in predicted DON across the state at the county scale; however, counties classified as high risk for I. scapularis–borne diseases and counties with known established populations of I. scapularis had the highest proportion of the county predicted as suitable for host-seeking nymphs (≥ 0.13 nymphs/100 m2). The model provides insight into areas of potential I. scapularis population expansion and identifies focal areas of predicted suitable habitat within counties where the incidence of I. scapularis–borne diseases has been historically low.
- 6 June 2018
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 98 (6) , 1671-1682
Open AccessAn Acarological Risk Model Predicting the Density and Distribution of Host-Seeking Ixodes scapularis Nymphs in Minnesota
Ixodes scapularis is the vector of at least seven human pathogens in Minnesota, two of which are known to cause Lyme disease (Borrelia burgdorferi sensu stricto and Borrelia mayonii). In Minnesota, the statewide incidence of Lyme disease and other I. scapularis–borne diseases and the geographic extent over which cases have been reported have both increased substantially over the last two decades. These changes correspond with an expanding distribution of I. scapularis over a similar time frame. Because the risk of exposure to I. scapularis–borne pathogens is likely related to the number of ticks encountered, we developed an acarological risk model predicting the density of host-seeking I. scapularis nymphs (DON) in Minnesota. The model was informed by sampling 81 sites located in 42 counties in Minnesota. Two main foci were predicted by the model to support elevated densities of host-seeking I. scapularis nymphs, which included the seven-county Minneapolis-St. Paul metropolitan area and counties in northern Minnesota, including Lake of the Woods and Koochiching counties. There was substantial heterogeneity observed in predicted DON across the state at the county scale; however, counties classified as high risk for I. scapularis–borne diseases and counties with known established populations of I. scapularis had the highest proportion of the county predicted as suitable for host-seeking nymphs (≥ 0.13 nymphs/100 m2). The model provides insight into areas of potential I. scapularis population expansion and identifies focal areas of predicted suitable habitat within counties where the incidence of I. scapularis–borne diseases has been historically low.